Aripiprazole Plasma Concentrations Delivered from Two 2-Month Long-Acting Injectable Formulations: An Indirect Comparison

Aripiprazole 2-month ready-to-use 960 mg (Ari 2MRTU 960) is a novel long-acting injectable (LAI) formulation of aripiprazole monohydrate for administration once every 2 months, developed for the treatment of schizophrenia or maintenance monotherapy treatment of bipolar I disorder in adults (indicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Harlin, Matthew, Chepke, Craig, Larsen, Frank, Bell Lynum, Karimah S, Chumki, Sanjeda R, Fitzgerald, Heather, Such, Pedro, Madera-McDonough, Jessica, Yildirim, Murat, Panni, Moeen, Saklad, Stephen R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259522/
https://www.ncbi.nlm.nih.gov/pubmed/37313228
http://dx.doi.org/10.2147/NDT.S412357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259522/
https://www.ncbi.nlm.nih.gov/pubmed/37313228
http://dx.doi.org/10.2147/NDT.S412357

Ejemplares similares